文献速递神经康复

ReWalk ReStore™软体机器人外骨骼:卒中后步态康复安全性、可靠性与可行性的多中心临床试验

The ReWalk ReStore™ soft robotic exosuit: a multi-site clinical trial of the safety, reliability, and feasibility of exosuit-augmented post-stroke gait rehabilitation.
PubMed 文献 · J Neuroeng Rehabil · 2020-06-18

该多中心临床试验纳入44例卒中后偏瘫患者,评估ReStore™软体外骨骼在步行训练中的安全性、可靠性和可行性。结果显示无设备相关跌倒或严重不良事件,设备故障率低;

要点

  • ReStore™软体外骨骼在物理治疗师指导下用于卒中后步态康复是安全可靠的。
  • 5天训练后患者设备辅助和未辅助最大步行速度均显著提升。
  • 研究为FDA申请准备,设备故障率低,无设备相关严重不良事件。

核心结论

  • 在持证物理治疗师指导下,ReStore™软体外骨骼用于卒中后步态康复是安全可靠的,可对患侧踝跖屈和背屈提供靶向辅助。

研究设计与样本

  • 多中心临床试验(NCT03499210),纳入44例卒中后偏瘫患者,完成最多5天跑台和地面ReStore™训练。

主要发现

  • 无设备相关跌倒或严重不良事件,临床操作者报告的设备故障率低。
  • 5天步行练习后,参与者设备辅助最大步行速度提高(Δ:0.10 ± 0.03 m/s,P < 0.05)。
  • 5天步行练习后,参与者未辅助最大步行速度提高(Δ:0.07 ± 0.03 m/s,P < 0.05)。

临床怎么用

  • 可在持证物理治疗师指导下,将ReStore™软体外骨骼用于卒中后跑台和地面步行训练,靶向辅助患侧踝跖屈和背屈。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atypical walking in the months and years after stroke constrain community reintegration and reduce mobility, health, and quality of life. The ReWalk ReStore™ is a soft robotic exosuit designed to assist the propulsion and ground clearance subtasks of post-stroke walking by actively assisting paretic ankle plantarflexion and dorsiflexion. Previous proof-of-concept evaluations of the technology demonstrated improved gait mechanics and energetics and faster and farther walking in users with post-stroke hemiparesis. We sought to determine the safety, reliability, and feasibility of using the ReStore™ during post-stroke rehabilitation. METHODS: A multi-site clinical trial (NCT03499210) was conducted in preparation for an application to the United States Food and Drug Administration (FDA). The study included 44 users with post-stroke hemiparesis who completed up to 5 days of training with the ReStore™ on the treadmill and over ground. In addition to primary and secondary endpoints of safety and device reliability across all training activities, an exploratory evaluation of the effect of multiple exposures to using the device on users' maximum walking speeds with and without the device was conducted prior to and following the five training visits. RESULTS: All 44 study participants completed safety and reliability evaluations. Thirty-six study participants completed all five training days. No device-related falls or serious adverse events were reported. A low rate of device malfunctions was reported by clinician-operators. Regardless of their reliance on ancillary assistive devices, after only 5 days of walking practice with the device, study participants increased both their device-assisted (Δ: 0.10 ± 0.03 m/s) and unassisted (Δ: 0.07 ± 0.03 m/s) maximum walking speeds (P's < 0.05). CONCLUSIONS: When used under the direction of a licensed physical therapist, the ReStore™ soft exosuit is safe and reliable for use during post-stroke gait rehabilitation to provide targeted assistance of both paretic ankle plantarflexion and dorsiflexion during treadmill and overground walking. TRIAL REGISTRATION: NCT03499210. Prospectively registered on March 28, 2018.

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Awad LN, Esquenazi A, Francisco GE, et al. The ReWalk ReStore™ soft robotic exosuit: a multi-site clinical trial of the safety, reliability, and feasibility of exosuit-augmented post-stroke gait rehabilitation. J Neuroeng Rehabil. 2020. PMID: 32552775. doi:10.1186/s12984-020-00702-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。